Literature DB >> 8734451

Insulin-like growth factor receptors and binding proteins.

D LeRoith1.   

Abstract

The insulin-like growth factor receptors are integral membrane proteins and demonstrate separate, but important effects on the regulation of cellular processes. The IGF-I receptor signals multiple cascades via its inherent tyrosine kinase activity. The IGF-II/M-6-P receptor on the other hand is primarily involved in targeting of enzymes to various subcellular compartments. In contrast, the insulin-like binding proteins are secreted by the cells and accumulate in the extracellular matrix or on the external surface of the cell. They are also involved in regulating cellular processes more indirectly. They modulate the interactions of the IGFs with their receptors, and in addition, may have some IGF-independent effects probably by direct interaction with integrin and other cell membrane receptor proteins. The recent studies, as outlined in this review, strongly suggest an important, if not essential role for the IGF system in normal physiology and disease states. The challenge now is to define the mechanisms involved in these effects. More studies are required to fully understand the post-receptor mechanism involved in IGF-I receptor signal transduction and the mechanisms whereby the IGFBPs exert their interesting effects. Understanding these mechanisms will enable investigators to create new therapeutic modalities for diseases that are affected by the IGF system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8734451     DOI: 10.1016/s0950-351x(96)80298-9

Source DB:  PubMed          Journal:  Baillieres Clin Endocrinol Metab        ISSN: 0950-351X


  11 in total

Review 1.  Insulin-like growth factors in the gastrointestinal tract and liver.

Authors:  John F Kuemmerle
Journal:  Endocrinol Metab Clin North Am       Date:  2012-05-15       Impact factor: 4.741

2.  Fibroblast growth factor-2 induces astroglial and microglial reactivity in vivo.

Authors:  Diane R Goddard; Martin Berry; Sara L Kirvell; Arthur M Butt
Journal:  J Anat       Date:  2002-01       Impact factor: 2.610

3.  Immunohistochemical analysis of insulin-like growth factor-binding proteins -1, -2, and -3 in implantation sites of the mouse.

Authors:  M A Damario; H C Liu; C A Mele; M G Horenstein; Z Rosenwaks
Journal:  J Assist Reprod Genet       Date:  1998-09       Impact factor: 3.412

Review 4.  Biological effects of growth hormone on carbohydrate and lipid metabolism.

Authors:  Archana Vijayakumar; Ruslan Novosyadlyy; Yingjie Wu; Shoshana Yakar; Derek LeRoith
Journal:  Growth Horm IGF Res       Date:  2009-10-01       Impact factor: 2.372

5.  Expression of IGFBP2 in gastric carcinoma and relationship with clinicopathologic parameters and cell proliferation.

Authors:  Lihua Zhang; Wenbin Huang; Jieyu Chen; Xiaojun Zhou; Zhenfeng Lu; Hangbo Zhou
Journal:  Dig Dis Sci       Date:  2006-12-15       Impact factor: 3.487

6.  The intricate role of growth hormone in metabolism.

Authors:  Archana Vijayakumar; Shoshana Yakar; Derek Leroith
Journal:  Front Endocrinol (Lausanne)       Date:  2011-09-27       Impact factor: 5.555

7.  Preoperative serum levels of insulin-like growth factor-binding protein 2 predict prognosis of gastric cancer patients.

Authors:  Hoon Hur; Eun Ji Yu; In-Hye Ham; Hye-Jin Jin; Dakeun Lee
Journal:  Oncotarget       Date:  2017-02-14

8.  Cryptochromes regulate IGF-1 production and signaling through control of JAK2-dependent STAT5B phosphorylation.

Authors:  Amol Chaudhari; Richa Gupta; Sonal Patel; Nikkhil Velingkaar; Roman Kondratov
Journal:  Mol Biol Cell       Date:  2017-01-18       Impact factor: 4.138

9.  Gene expression and prognosis of insulin‑like growth factor‑binding protein family members in non‑small cell lung cancer.

Authors:  Jiao Wang; Zhi-Guo Hu; Dan Li; Ji-Xion Xu; Zhen-Guo Zeng
Journal:  Oncol Rep       Date:  2019-09-16       Impact factor: 3.906

10.  An investigation on the relevance of prolactin, insulin-like growth factor-1 and 25-hydroxyvitamin D3 (25-OHD3 ) in canine benign prostatic hyperplasia in a predisposed breed model.

Authors:  Franziska Werhahn Beining; Marion Schmicke; Mirja Wilkens; Karola Wolf; Karl Rohn; Anne-Rose Günzel-Apel
Journal:  Vet Med Sci       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.